NASDAQ:MBX - Nasdaq - US55287L1017 - Common Stock - Currency: USD
TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | ||||
---|---|---|---|---|---|---|---|
Revenue | 0.00 | 0.00 | 0.00 | 0.00 | |||
Operating Expenses | 81.41M | 68.19M | 35.31M | 25.16M | |||
Research and Development | 68.77M | 57.41M | 28.53M | 21.40M | |||
Selling, General, and Administrative Expenses | 12.64M | 10.78M | 6.78M | 3.76M | |||
Operating Income | -81.41M | -68.19M | -35.31M | -25.16M | |||
Interest Income/Expense | 7.94M | 6.27M | 2.75M | -75.00K | |||
Non Recurring Items | N/A | N/A | 0.00 | -899.00K | |||
Income Before Taxes | -73.47M | -61.92M | -32.56M | -26.14M | |||
Net Income | -73.47M | -61.92M | -32.56M | -26.14M | |||
EBITDA | -81.14M | -67.95M | -35.15M | -25.11M | |||
Per Share Data | |||||||
EPS Diluted Total Ops | -3.22 | -5.82 | -1.02 | -0.82 | |||
Statistics |
All data in USD